Lessee, Operating Lease, Liability, to be Paid in USD of Lexaria Bioscience Corp. from Q3 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Lexaria Bioscience Corp. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q3 2020 to Q2 2025.
  • Lexaria Bioscience Corp. Lessee, Operating Lease, Liability, to be Paid for the quarter ending May 31, 2025 was $132K, a 21% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)

Lexaria Bioscience Corp. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $132K -$35.1K -21% May 31, 2025 10-Q 2025-07-14
Q1 2025 $142K -$34.7K -19.7% Feb 28, 2025 10-Q 2025-04-14
Q4 2024 $151K -$34.3K -18.5% Nov 30, 2024 10-Q 2025-01-10
Q3 2024 $160K -$34.2K -17.6% Aug 31, 2024 10-K 2024-11-26
Q2 2024 $167K May 31, 2024 10-Q 2024-07-12
Q1 2024 $176K -$29.1K -14.2% Feb 29, 2024 10-Q 2024-04-09
Q4 2023 $185K +$144K +351% Nov 30, 2023 10-Q 2024-01-12
Q3 2023 $194K Aug 31, 2023 10-K 2023-11-20
Q1 2023 $206K +$131K +175% Mar 31, 2023 10-Q 2023-07-14
Q4 2022 $41.1K -$44.8K -52.2% Nov 30, 2022 10-Q/A 2023-01-18
Q2 2022 $52.3K -$55.6K -51.5% May 31, 2022 10-K 2022-11-28
Q1 2022 $74.7K -$44.2K -37.2% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 $85.9K -$43.9K -33.8% Nov 30, 2021 10-Q 2022-01-14
Q3 2021 $96.9K -$43.9K -31.2% Aug 31, 2021 10-K 2021-11-29
Q2 2021 $108K May 31, 2021 10-Q 2021-07-15
Q1 2021 $119K Feb 28, 2021 10-Q 2021-04-14
Q4 2020 $130K Nov 30, 2020 10-Q 2021-01-14
Q3 2020 $141K Aug 31, 2020 10-K 2020-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.